Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults
by
Douoguih, Macaya
, Ervin, John
, Chan, Eric K.H.
, Sadoff, Jerald
, Vandenberghe, Sjouke
, Bart, Stephan
, Callendret, Benoit
, De Paepe, Els
, Comeaux, Christy A.
, Heijnen, Esther
, Gymnopoulou, Efi
, Falsey, Ann R.
, Williams, Kristi
, Bastian, Arangassery R.
, Menten, Joris
in
Adverse events
/ Age
/ Aged
/ Aging
/ Aging General
/ Antibodies, Neutralizing - blood
/ Antibodies, Neutralizing - immunology
/ Antibodies, Viral - blood
/ Antibodies, Viral - immunology
/ Coronaviruses
/ COVID-19
/ Disease prevention
/ Double-Blind Method
/ Double-blind studies
/ Enzymes
/ FDA approval
/ Geriatrics
/ Global Health
/ Humans
/ Immunogenicity
/ Immunogenicity, Vaccine - immunology
/ Infections
/ Infectious Disease
/ Infectious Disease General
/ Older people
/ Participation
/ Placebos
/ Proteins
/ Respiratory syncytial virus
/ Respiratory Syncytial Virus Infections - blood
/ Respiratory Syncytial Virus Infections - immunology
/ Respiratory Syncytial Virus Infections - prevention & control
/ Respiratory Syncytial Virus Vaccines - adverse effects
/ Respiratory Syncytial Virus Vaccines - therapeutic use
/ Respiratory Syncytial Virus, Human - immunology
/ Respiratory tract diseases
/ Respiratory Tract Infections - blood
/ Respiratory Tract Infections - immunology
/ Respiratory Tract Infections - prevention & control
/ Treatment Outcome
/ Vaccine Efficacy
/ Vaccines
/ Viral Infections
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults
by
Douoguih, Macaya
, Ervin, John
, Chan, Eric K.H.
, Sadoff, Jerald
, Vandenberghe, Sjouke
, Bart, Stephan
, Callendret, Benoit
, De Paepe, Els
, Comeaux, Christy A.
, Heijnen, Esther
, Gymnopoulou, Efi
, Falsey, Ann R.
, Williams, Kristi
, Bastian, Arangassery R.
, Menten, Joris
in
Adverse events
/ Age
/ Aged
/ Aging
/ Aging General
/ Antibodies, Neutralizing - blood
/ Antibodies, Neutralizing - immunology
/ Antibodies, Viral - blood
/ Antibodies, Viral - immunology
/ Coronaviruses
/ COVID-19
/ Disease prevention
/ Double-Blind Method
/ Double-blind studies
/ Enzymes
/ FDA approval
/ Geriatrics
/ Global Health
/ Humans
/ Immunogenicity
/ Immunogenicity, Vaccine - immunology
/ Infections
/ Infectious Disease
/ Infectious Disease General
/ Older people
/ Participation
/ Placebos
/ Proteins
/ Respiratory syncytial virus
/ Respiratory Syncytial Virus Infections - blood
/ Respiratory Syncytial Virus Infections - immunology
/ Respiratory Syncytial Virus Infections - prevention & control
/ Respiratory Syncytial Virus Vaccines - adverse effects
/ Respiratory Syncytial Virus Vaccines - therapeutic use
/ Respiratory Syncytial Virus, Human - immunology
/ Respiratory tract diseases
/ Respiratory Tract Infections - blood
/ Respiratory Tract Infections - immunology
/ Respiratory Tract Infections - prevention & control
/ Treatment Outcome
/ Vaccine Efficacy
/ Vaccines
/ Viral Infections
2023
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults
by
Douoguih, Macaya
, Ervin, John
, Chan, Eric K.H.
, Sadoff, Jerald
, Vandenberghe, Sjouke
, Bart, Stephan
, Callendret, Benoit
, De Paepe, Els
, Comeaux, Christy A.
, Heijnen, Esther
, Gymnopoulou, Efi
, Falsey, Ann R.
, Williams, Kristi
, Bastian, Arangassery R.
, Menten, Joris
in
Adverse events
/ Age
/ Aged
/ Aging
/ Aging General
/ Antibodies, Neutralizing - blood
/ Antibodies, Neutralizing - immunology
/ Antibodies, Viral - blood
/ Antibodies, Viral - immunology
/ Coronaviruses
/ COVID-19
/ Disease prevention
/ Double-Blind Method
/ Double-blind studies
/ Enzymes
/ FDA approval
/ Geriatrics
/ Global Health
/ Humans
/ Immunogenicity
/ Immunogenicity, Vaccine - immunology
/ Infections
/ Infectious Disease
/ Infectious Disease General
/ Older people
/ Participation
/ Placebos
/ Proteins
/ Respiratory syncytial virus
/ Respiratory Syncytial Virus Infections - blood
/ Respiratory Syncytial Virus Infections - immunology
/ Respiratory Syncytial Virus Infections - prevention & control
/ Respiratory Syncytial Virus Vaccines - adverse effects
/ Respiratory Syncytial Virus Vaccines - therapeutic use
/ Respiratory Syncytial Virus, Human - immunology
/ Respiratory tract diseases
/ Respiratory Tract Infections - blood
/ Respiratory Tract Infections - immunology
/ Respiratory Tract Infections - prevention & control
/ Treatment Outcome
/ Vaccine Efficacy
/ Vaccines
/ Viral Infections
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults
Journal Article
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults
2023
Request Book From Autostore
and Choose the Collection Method
Overview
A combination of adenovirus 26 and protein vaccines was used to deliver a prefusion stabilized RSV protein. RSV-related lower respiratory tract illness developed in fewer vaccine recipients than placebo recipients.
Publisher
Massachusetts Medical Society
Subject
/ Age
/ Aged
/ Aging
/ Antibodies, Neutralizing - blood
/ Antibodies, Neutralizing - immunology
/ Antibodies, Viral - immunology
/ COVID-19
/ Enzymes
/ Humans
/ Immunogenicity, Vaccine - immunology
/ Placebos
/ Proteins
/ Respiratory Syncytial Virus Infections - blood
/ Respiratory Syncytial Virus Infections - immunology
/ Respiratory Syncytial Virus Infections - prevention & control
/ Respiratory Syncytial Virus Vaccines - adverse effects
/ Respiratory Syncytial Virus Vaccines - therapeutic use
/ Respiratory Syncytial Virus, Human - immunology
/ Respiratory Tract Infections - blood
/ Respiratory Tract Infections - immunology
/ Respiratory Tract Infections - prevention & control
/ Vaccines
This website uses cookies to ensure you get the best experience on our website.